{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:23:20Z","timestamp":1787743400845,"version":"build-2784847793"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"National Institute of Child Health and Human Development","award":["R01HD 086139"],"award-info":[{"award-number":["R01HD 086139"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["5T35DK007386-43"],"award-info":[{"award-number":["5T35DK007386-43"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["Co-Support Research Award"],"award-info":[{"award-number":["Co-Support Research Award"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the association between maternal metformin use for the treatment of early gestational or pre-existing type 2 diabetes and preterm preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This is a planned secondary analysis of the MOMPOD study (Medical Optimization of Management of Overt Type 2 Diabetes in Pregnancy), a randomized trial comparing the effect of adding metformin with insulin treatment on composite neonatal outcome in singleton pregnancies with early gestational or type 2 diabetes. Participants were randomized at 11\u201323 weeks of gestation to 1,000 mg metformin twice daily or placebo until delivery. A subset of participants had maternal blood collected at 24\u201330 weeks of gestation, and serum soluble endoglin, apolipoprotein B, vascular cell adhesion molecule-1, soluble fms-like tyrosine kinase 1, placental growth factor, high-sensitivity C-reactive protein, adiponectin, and vascular endothelial growth factor levels were measured. Our primary outcome was\n                      <jats:italic toggle=\"yes\">preterm preeclampsia<\/jats:italic>\n                      , defined as preeclampsia requiring delivery before 37 weeks of gestation. Secondary outcomes included preterm preeclampsia requiring delivery before 34 weeks of gestation and differences in serum biomarkers. Multivariable regression analysis was used to estimate the associations between metformin use and primary or secondary study outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 831 participants, 119 (14.3%) developed preeclampsia requiring delivery before 37 weeks of gestation: 57 of 416 (13.7%) in the placebo group and 62 of 415 (14.9%) in the metformin group. Thirty-seven (4.4%) developed preeclampsia requiring delivery before 34 weeks of gestation: 15 (3.6%) receiving placebo and 22 (5.3%) receiving metformin. Compared with placebo, metformin was not associated with a significant difference in the occurrence of preeclampsia before 37 weeks of gestation (adjusted odds ratio [aOR] 1.04, 95% CI, 0.70\u20131.56) or before 34 weeks (aOR 1.43, 95% CI, 0.73\u20132.81). Similarly, there was no association between maternal metformin use and serum biomarker levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Among parturients with early gestational or pre-existing type 2 diabetes, the addition of metformin to insulin was not associated with lower odds of preterm preeclampsia or with serum biomarkers associated with cardiovascular disease risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005720","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T17:18:23Z","timestamp":1725556703000},"page":"733-739","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia"],"prefix":"10.1097","volume":"144","author":[{"given":"Maya","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Battarbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrie S.","family":"Refuerzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Zork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey","family":"Eichelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys A.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Durnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Landon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti M.","family":"Aagaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedra","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Scifres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadia","family":"Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ogc.2007.03.002","article-title":"The increasing prevalence of diabetes in pregnancy","volume":"34","author":"Hunt","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1751-7176.2011.00440.x","article-title":"Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies","volume":"13","author":"Sullivan","year":"2011","journal-title":"J Clin Hypertens"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1758-5996-4-41","article-title":"Adverse pregnancy outcomes in women with diabetes","volume":"4","author":"Negrato","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr Diab Rep"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in Women With Type 2 Diabetes in Pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"e0228743","DOI":"10.1371\/journal.pone.0228743","article-title":"Impact of diabetes, obesity and hypertension on preterm birth: population-based study","volume":"15","author":"Berger","year":"2020","journal-title":"PLoS One"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.3390\/jcm11206048","article-title":"Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease\u2014a review","volume":"11","author":"S\u0142awek-Szmyt","year":"2022","journal-title":"J Clin Med"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.117.09246","article-title":"All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease","volume":"70","author":"Tooher","year":"2017","journal-title":"Hypertension"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/epirev\/mxt006","article-title":"Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?","volume":"36","author":"Rich-Edwards","year":"2014","journal-title":"Epidemiol Rev"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9378(86)90336-4","article-title":"Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis","volume":"155","author":"Sibai","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"e002406","DOI":"10.1136\/bmjdrc-2021-002406","article-title":"Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study","volume":"9","author":"Ahmadizar","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus: the Multicenter Metformin Study Group","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diacare.17.10.1100","article-title":"Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations: a double-blind controlled study","volume":"17","author":"Hermann","year":"1994","journal-title":"Diabetes Care"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2165\/00002018-200730120-00005","article-title":"Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus","volume":"30","author":"Hermansen","year":"2007","journal-title":"Drug Saf"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jdiacomp.2005.08.010","article-title":"Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73","volume":"20","author":"Wright","year":"2006","journal-title":"J Diabetes Complications"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"327.e1","DOI":"10.1016\/j.ajog.2011.02.024","article-title":"Maternal insulin resistance and preeclampsia","volume":"204","author":"Hauth","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","article-title":"Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity","volume":"217","author":"Romero","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/jcm10132805","article-title":"Prevention of hypertensive disorders of pregnancy: is there a place for metformin?","volume":"10","author":"Poniedzia\u0142ek-Czajkowska","year":"2021","journal-title":"J Clin Med"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1080\/14767058.2016.1228061","article-title":"Metformin\u2014a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis","volume":"30","author":"Feng","year":"2017","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"325851","DOI":"10.1155\/2015\/325851","article-title":"Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy","volume":"2015","author":"Ainuddin","year":"2015","journal-title":"J Diabetes Res"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12884-018-2108-3","article-title":"Rationale, design, and methods for the Medical Optimization and Management of Pregnancies With Overt Type 2 Diabetes (MOMPOD) study","volume":"18","author":"Berry","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/jama.2023.22949","article-title":"Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy: the MOMPOD randomized clinical trial","volume":"330","author":"Boggess","year":"2023","journal-title":"JAMA"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0002-9378(00)70225-0","article-title":"Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"182","author":"Sibai","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of Metformin on Maternal and Fetal Outcomes in Obese Pregnant Women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N Engl J Med"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fendo.2020.00191","article-title":"Metformin and its benefits for various diseases","volume":"11","author":"Lv","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble FMS-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2172-11-59","article-title":"Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array","volume":"11","author":"Szarka","year":"2010","journal-title":"BMC Immunol"},{"key":"R35-20260826","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2015.07.017","article-title":"Metformin modulates human leukocyte\/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients","volume":"242","author":"Victor","year":"2015","journal-title":"Atherosclerosis"},{"key":"R36-20260826","doi-asserted-by":"crossref","first-page":"n2103","DOI":"10.1136\/bmj.n2103","article-title":"Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial","volume":"374","author":"Cluver","year":"2021","journal-title":"BMJ"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:00:30Z","timestamp":1787742030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005720","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"2024-05-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}